Literature DB >> 8302724

Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas.

M Polette1, C Clavel, P Birembaut, Y A De Clerck.   

Abstract

The presence and distribution of mRNAs encoding a matrix metalloproteinase (MMP) stromelysin 3 and two tissue inhibitors of MMP, TIMP1 and TIMP-2 have been studied by in situ hybridization of 18 human epidermoid head and neck carcinomas and four normal tissues. We found that in 16 tumors out of 18, stromelysin 3 mRNAs were only expressed by fibroblasts which were in close contact to invasive cancer cells. Tumor cells and normal tissues were not labeled. TIMP-1 mRNAs were detected in well differentiated cancer cells and in endothelial cells in all the cancers. In 13 out of the 18 carcinomas, TIMP-2 mRNAs were localized in only a few stromal cells near well differentiated invasive cancer cells and in endothelial cells. The significant expression of TIMP-1 and TIMP-2 mRNAS may lead to less aggressive MMPs, especially in the case of stromelysin 3, in the invasive process of the stroma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8302724     DOI: 10.1016/S0344-0338(11)80679-5

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  13 in total

1.  Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck.

Authors:  N Johansson; K Airola; R Grénman; A L Kariniemi; U Saarialho-Kere; V M Kähäri
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 2.  The matrix metalloproteinases and their inhibitors in pancreatic cancer. From molecular science to a clinical application.

Authors:  S R Bramhall
Journal:  Int J Pancreatol       Date:  1997-02

Review 3.  Matrix metalloproteinase inhibitors.

Authors:  S M Wojtowicz-Praga; R B Dickson; M J Hawkins
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

4.  Stromelysin-3 expression in early (pT1) carcinomas and pseudoinvasive lesions of the colorectum.

Authors:  J Mueller; E Mueller; E Arras; B Bethke; M Stolte; H Höfler
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

5.  Localization of messenger RNA for tissue inhibitor of metalloproteinases-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas.

Authors:  C K Lindsay; U P Thorgeirsson
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

6.  On the theory of tumor self-seeding: implications for metastasis progression in humans.

Authors:  Julio A Aguirre-Ghiso
Journal:  Breast Cancer Res       Date:  2010-04-28       Impact factor: 6.466

Review 7.  Invasion and metastasis.

Authors:  D Boyd
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

8.  In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.

Authors:  Larisa M Haupt; Erik W Thompson; Ann E O Trezise; Rachel E Irving; Michael G Irving; Lyn R Griffiths
Journal:  BMC Cancer       Date:  2006-01-24       Impact factor: 4.430

9.  Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo.

Authors:  U Schönbeck; F Mach; G K Sukhova; E Atkinson; E Levesque; M Herman; P Graber; P Basset; P Libby
Journal:  J Exp Med       Date:  1999-03-01       Impact factor: 14.307

10.  Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.

Authors:  M Sutinen; T Kainulainen; T Hurskainen; E Vesterlund; J P Alexander; C M Overall; T Sorsa; T Salo
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.